By annette
Cancer Patients Europe (CPE) organized a high-level event at the European Parliament on 23rd April hosted by MEP Tomislav Sokol to mark the launch of “the Call to Action: 5 Ways to Reduce Cancer Care Inequalities in Europe”. IHE contributed to the evidence base of this Call to Action through the IHE Report on “Tackling …
By annette
The report analyzes and compares the cancer situation in Europe. It provides a comprehensive view of the development of cancer between 1995 and 2023. Read more
By annette
On March 10th, Oskar Frisell assumed the role of co-chair for health economics at Genomic Medicine Sweden (GMS). He brings extensive experience in health economics research, with a particular focus on precision medicine and precision health. In his new role at GMS, Oskar will apply his expertise in areas such as cost-effectiveness analysis and policy …
By annette
In PharmacoEconomics on the heterogeneity in comparative economic analysis, with specific considerations for the decentralized US Setting and patient-centered care. Read more and download the article
By annette
The Swedish Institute for Health Economics welcomes David Gabrielsson who joined our team this week. David works as an Analyst at our Stockholm office.
By annette
This retrospective population-based study used Swedish registers with health-data on patients with BC/RCC and matched controls with diabetes but no cancer. The high prevalence of diabetes and increased use of systemic corticosteroid treatment observed in this large national study highlights the need for specific clinical management, risk-assessment, and monitoring of individuals with BC/RCC and diabetes. …
By annette
Following the Covid-19 pandemic in 2020 — 2022, decision makers in Europe imposed nonpharmaceutical interventions (NPIs) to reduce the physical interaction of individuals across the continent. The aim was to reduce the spread of disease; however, the interventions and the behavioral changes also came at a cost, both in terms of quality of life and …
By annette
National Cancer Control Programs (NCCPs) are recognized by the WHO as the gold standard for reducing cancer incidence and mortality in a strategic way. Saudi Arabia is a country working to update its NCCP in 2025. At a workshop with local experts and international speakers from IARC and UICC in Riyadh, IHE’s Thomas Hofmarcher shared …
By annette
What are challenges women with endometrial cancer face in Canada? Our first country-specific case study provides a comprehensive overview of the disease and economic burden and the care pathway. It also provides recommendations for improvement. Read more and download
By annette
The report puts a spotlight on the disease burden, cancer prevention, early detection, and the sustainability of cancer care systems. Läs mer